Metformin Hydrochloride; Rosiglitazone Maleate Patent Expiration
Metformin Hydrochloride; Rosiglitazone Maleate is Used for managing and treating type 2 diabetes mellitus. It was first introduced by Sb Pharmco Puerto Rico Inc
Metformin Hydrochloride; Rosiglitazone Maleate Patents
Given below is the list of patents protecting Metformin Hydrochloride; Rosiglitazone Maleate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Avandamet | US8236345 | Composition and use |
Oct 07, 2022
(Expired) | Sb Pharmco |
| Avandamet |
US7358366 (Pediatric) | Thiazolidinedione derivative and its use as antidiabetic |
Oct 19, 2020
(Expired) | Sb Pharmco |
| Avandamet | US7358366 | Thiazolidinedione derivative and its use as antidiabetic |
Apr 19, 2020
(Expired) | Sb Pharmco |
| Avandamet |
US6288095 (Pediatric) | Compounds |
Aug 11, 2017
(Expired) | Sb Pharmco |
| Avandamet | US6288095 | Compounds |
Feb 11, 2017
(Expired) | Sb Pharmco |
| Avandamet | US5965584 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Sb Pharmco |
| Avandamet | US6166042 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Sb Pharmco |
| Avandamet |
US5741803 (Pediatric) | Substituted thiazolidinedionle derivatives |
Oct 21, 2015
(Expired) | Sb Pharmco |
| Avandamet | US5741803 | Substituted thiazolidinedionle derivatives |
Apr 21, 2015
(Expired) | Sb Pharmco |
Metformin Hydrochloride; Rosiglitazone Maleate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List